Ciprofloxacin Liposomes as Vesicular Reservoirs for Ocular Delivery: Formulation, Optimization, and In Vitro Characterization

REFERENCES

• J. Al-Muhammed, A. Y. Ozer, and A. A. Hincal. (1996). In-vivo studies on dexamethasone sodium phosphate liposomes. J. Microencapsul. 13:293–306.
   PubMed Web of Science ®Google Scholar
• M. J. Alonso. (2004). Nanomedicines for overcoming biological barriers. Biomed. Pharmacother. 58:168–172.
   PubMed Web of Science ®Google Scholar
• H. B. Arnardottir, S. J. Sveinsson, and T. Kristmundsdottir. (1996). The release of clindamycin phosphate from a suspension of different types of liposomes and selected topical dosages forms. Int. J. Pharm. 134:71–77.
   Google Scholar
• V. Baeyens, O. Felt-Baeyens, S. Rougier, S. Pheulpin, B. Boisrame, and R. Gurny. (2002). Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infection in dogs. J. Control. Release 85:163–168.
   PubMed Web of Science ®Google Scholar
• L. Budai, M. Hajdu, M. Budai, P. Grof, S. Beni, B. Noszal, I. Klebovich, and I. Antal. (2007). Gels and liposomes in optimized ocular drug delivery: Studies on ciprofloxacin formulations. Int. J. Pharm. 343:34–40.
   PubMed Web of Science ®Google Scholar
• N. L. Burstein, and J. A. Anderson. (1985). Review: Corneal penetration and ocular availability of drugs. J. Ocul. Pharmacol. 1:309–326.
   PubMedGoogle Scholar
• R. Cortesi, R. Argnani, E. Esposito, A. Dalpiaz, A. Scatturin, F. Bortolotti, M. Lufino, R. Guerrini, G. Cavicchioni, C. Incorvaia, E. Menegatti, and R. Manservigi. (2006). Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity. Int. J. Pharm. 317:90–100.
   PubMed Web of Science ®Google Scholar
• R. Cortesi, R. Romagnoli, E. Menegatti, and E. Esposito. (2004). Liposomes containing distamycins: Preparation, characterization and antiproliferation activity. Drug Deliv. 11:83–88.
   PubMed Web of Science ®Google Scholar
• N. M. Davies. (2000). Biopharmaceutical considerations in topical ocular drug delivery. Clin. Exp. Pharmacol. Physiol. 27:558–562.
   PubMed Web of Science ®Google Scholar
• K. Dillen, J. Vandervoort, G. V. Mooter, L. Verheyden, and A. Ludwig. (2004). Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int. J. Pharm. 275:171–187.
   PubMed Web of Science ®Google Scholar
• S. Ebrahim, G. A. Peyman, and J. P. Lee. (2005). Applications of liposomes in ophthamology. Surv. Ophthalmol. 50:167–182.
   PubMed Web of Science ®Google Scholar
• O. N. El-Gazayerly, and A. H. Hikal. (1997). Preparation and evaluation of acetazolamide liposomes as ocular delivery systems. Int. J. Pharm. 158:121–127.
   Web of Science ®Google Scholar
• Y. X. Furet, J. Deshusses, and J. C. Pechere. (1992). Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphilococcus aureus. Antimicrob. Agents Chemother. 36:2506–2511.
   PubMed Web of Science ®Google Scholar
• J. Hernandez-Borrell, and M. T. Montero. (2003). Does ciprofloxacin interact with neutral bilayers? An aspect related to its antimicrobial activity. Int. J. Pharm. 252:149–157.
   PubMedGoogle Scholar
• P. Jedlovsky, and M. Mezei. (2003). Effect of cholesterol on the properties of phospholipid membranes. 1. Structural features. J. Phys. Chem. B 107:5311–5321.
   Web of Science ®Google Scholar
• I. P. Kaur, and M. Kanwar. (2002). Ocular preparations: The formulation approach. Drug Dev. Ind. Pharm. 28:473–493.
   PubMed Web of Science ®Google Scholar
• I. P. Kaur, and R. Smitha. (2002). Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev. Ind. Pharm. 28:353–369.
   PubMed Web of Science ®Google Scholar
• M. Koppcha, N. Lordi, and K. J. Tojo. (1991). Evaluation of release from selected thermosoftening vehicles. J. Pharm. Pharmacol. 43:382–387.
   PubMed Web of Science ®Google Scholar
• S. L. Law, and H. Y. Hung. (1998). Properties of acyclovir-containing liposomes for potential ocular delivery. Int. J. Pharm. 161:253–259.
   Web of Science ®Google Scholar
• C. L Le Bourlais, L. Acar, H. Zia, P. A. Sado, T. Needham, and R. Leverge. (1998). Ophthalmic drug delivery systems-recent advances. Prog. Retin. Eye Res. 17:33–58.
   PubMed Web of Science ®Google Scholar
• G. A. Lewis, D. Mathieu, and R. Phan-Tan-Luu. (1999). Pharmaceutical experimental design. New York: Marcel Dekker Inc.
   Google Scholar
• W. Liang, T. S. Levchenko, and V. P. Torchilin. (2004). Encapsulation of ATP into liposomes by different methods: Optimization of the procedure. J. Microencapsul. 21:251–261.
   PubMed Web of Science ®Google Scholar
• C. Liu, K. G. H. Desai, X. Tang, and X. Chen. (2006). Drug release kinetics of spray-dried chitosan microspheres. Drying Tech. 24:769–776.
   Web of Science ®Google Scholar
• P. Maffei, S. Lombardi Borgia, A. Sforzini, V. Bergamante, and G. C. Ceschel. (2004). Mucoadhesive tablets for buccal administration containing sodium nimesulide. Drug Deliv. 11:225–230.
   PubMed Web of Science ®Google Scholar
• R. M. Mainardes, M. C. Urban, P. O. Cinto, N. M. Khalil, M. V. Chaud, R. C. Evangelista, and M. P. Gremiao. (2005). Colloidal carriers for ophthalmic drug delivery. Curr. Drug Targets 6:363–371.
   PubMed Web of Science ®Google Scholar
• M. S. Nagarsenker, V. Y. Londhe, and G. D. Nadkarni. (1999). Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery. Int. J. Pharm. 190:63–71.
   PubMed Web of Science ®Google Scholar
• P. Perugini, I. Genta, F. Pavanetto, B. Conti, S. Scalia, and A. Baruffini. (2000). Study on glycolic acid delivery by liposomes and microspheres. Int. J. Pharm. 196:51–61.
   PubMed Web of Science ®Google Scholar
• R. Peschka-Suss, C. Dennehy, and F. Szoka. (1998). A simple in vitro model to study the release kinetics of liposome encapsulated material. J. Control. Release 56:41–51.
   PubMed Web of Science ®Google Scholar
• G. Puglisi, M. Fresta, G. Mazzone, P. M. Furneri, and G. Tempera. (1995). Formulation parameters of fluoroquinolone-loaded liposomes and in vitro antimicrobial activity. Int. J. Pharm. 118:65–76.
   Web of Science ®Google Scholar
• P. Santo, S. Bufali, C. Pisano, F. Bucci, M. Barbarino, M. Santaniello, P. Carminati, and P. L. Luisi. (2004). Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method. J. Liposome Res. 14:87–109.
   PubMed Web of Science ®Google Scholar
• H. Sasaki, T. Nagono, K. Sakanaka, S. Kawakami, K. Nishida, J. Nakamura, N. Khikawa, J. Iwashita, T. Nakamura, and M. Nakashima. (2003). One-side coated insert as unique ophthalmic drug delivery system. J. Control. Release 92:241–247.
   PubMed Web of Science ®Google Scholar
• A. E. Seham, S. B. Sabry, and A. B. Alia. (1996). Optimization of a reconstitutable suspension of rifampicin using 24 factorial design. Drug Dev. Ind. Pharm. 22:623–630.
   Web of Science ®Google Scholar
• A. K. Seth, and A. Misra. (2002). Mathematical modelling of preparation of acyclovir liposomes: Reverse phase evaporation method. J. Pharm. Pharm. Sci. 5:285–291.
   PubMed Web of Science ®Google Scholar
• J. W. Shell. (1984). Ophthalmic drug delivery systems. Surv. Ophthalmol. 29:117–128.
   PubMed Web of Science ®Google Scholar
• J. W. Shell, and R. Baker. (1974). Diffusional systems for controlled release of drugs to the eye. Ann. Ophthalmol. 6:1037–1043.
   PubMed Web of Science ®Google Scholar
• K. X. Sun, A. P. Wang, L. J. Huang, R. C. Liang, and K. Liu. (2006). Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics. Acta Pharmacol. Sin. 41:1094–1098.
   Google Scholar
• F. Szoka, and D. Papahadjopoulos. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse phase evaporation. Proc. Natl. Acad. Sci. USA 75:4194–4198.
   PubMed Web of Science ®Google Scholar
• R. M. Verly, M. A. Rodrigues, K. R. P. Daghastanli, A. M. L. Denadai, I. M. Cuccovia, C. BlochJr, F. Frézard, M. M. Santoro, D. Piló-Veloso, and M. P. Bemquerer. (2008). Effect of cholesterol on the interaction of the amphibian antimicrobial peptide DD K with liposomes. Peptides 29:15–24.
   PubMed Web of Science ®Google Scholar
• A. H. Wen, M. K. Choi, and D. D. Kim. (2006). Formulation of liposome for topical delivery of arbutin. Arch. Pharm. Res. 29:1187–1192.
   PubMed Web of Science ®Google Scholar
• A. Zimmer, and J. Kreuter. (1995). Microspheres and nanoparticles used in ocular delivery systems. Adv. Drug Deliv. Rev. 16:61–73.
   Web of Science ®Google Scholar